Literature DB >> 186410

Viral infections in renal transplant recipients.

J A Armstrong, A S Evans, N Rao, M Ho.   

Abstract

Cytomegalovirus (CMV) infections are common in renal transplant recipients. We studied 23 recipients prospectively to determine whether infections by other herpes-group and non-herpes-group viruses were also present. Sera, obtained at the time of surgery and periodically thereafter, were tested for antibody to CMV, herpes simplex virus (HSV), Epstein-Barr virus (EBV), parainfluenza viruses types 1, 2, and 3, and the viruses of measles and rubella. We found no evidence of an unusual incidence of primary or secondary infection by the non-herpesviruses tested. Rises to CMV, HSV, and EBV antibody titers occurred in 43, 38, and 32% of patients, respectively. All serological rises to herpes-group viruses occurred in patients seropositive at the time of transplantation, with the exception of three patients who experienced primary CMV infections. We conclude that reactivation of all herpes-group viruses tested may occur in transplant recipients. Morbidity was associated only with primarly CMV infection.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 186410      PMCID: PMC415480          DOI: 10.1128/iai.14.4.970-975.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  REPORT OF A CASE WITH ISOLATION OF VIRUS.

Authors:  E T HEDLEY-WHYTE; J E CRAIGHEAD
Journal:  N Engl J Med       Date:  1965-03-04       Impact factor: 91.245

2.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

3.  Association of renal allograft rejection with virus infections.

Authors:  C Lopez; R L Simmons; S M Mauer; J S Najarian; R A Good; S Gentry
Journal:  Am J Med       Date:  1974-03       Impact factor: 4.965

4.  Relationship between cytomegalovirus and hepatic function abnormalities in the period after renal transplant.

Authors:  J P Luby; W Burnett; A R Hull; A J Ware; J W Shorey; P C Peters
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

5.  A seroepidemiological study of Epstein-Barr virus and other viral antigens in sarcoidosis.

Authors:  E B Byrne; A S Evans; D W Fouts; H L Israel
Journal:  Am J Epidemiol       Date:  1973-05       Impact factor: 4.897

6.  Antibodies to the Epstein-Barr virus in kidney transplant recipients.

Authors:  E S Spencer; H K Andersen
Journal:  Acta Med Scand       Date:  1972 Jan-Feb

7.  Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs.

Authors:  B Strauch; L L Andrews; N Siegel; G Miller
Journal:  Lancet       Date:  1974-02-16       Impact factor: 79.321

8.  The activation of varicella-zoster virus infections by immunosuppressive therapy.

Authors:  D Rifkind
Journal:  J Lab Clin Med       Date:  1966-09

9.  Epidemiology of cytomegalovirus infection after transplantation and immunosuppression.

Authors:  M Fiala; J E Payne; T V Berne; T C Moore; W Henle; J Z Montgomerie; S N Chatterjee; L B Guze
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

10.  The transplanted kidney as a source of cytomegalovirus infection.

Authors:  M Ho; S Suwansirikul; J N Dowling; L A Youngblood; J A Armstrong
Journal:  N Engl J Med       Date:  1975-11-27       Impact factor: 91.245

  10 in total
  20 in total

Review 1.  Hodgkin's disease and the Epstein-Barr virus.

Authors:  K J Flavell; P G Murray
Journal:  Mol Pathol       Date:  2000-10

2.  General features of persistent virus infections.

Authors:  C A Mims
Journal:  Postgrad Med J       Date:  1978-09       Impact factor: 2.401

3.  Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods.

Authors:  C L Howell; M J Miller; W J Martin
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

4.  Cytomegalovirus infection and graft survival in renal graft recipients.

Authors:  R Cappel; O Hestermans; C Toussaint; P Vereerstraeten; D van Beers; J de Braekeleer; E Schoutens
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

5.  Herpes simplex keratitis in renal transplant patients.

Authors:  I Kremer; A Wagner; D Shmuel; A Yussim; Z Shapira
Journal:  Br J Ophthalmol       Date:  1991-02       Impact factor: 4.638

6.  Virus infections after transplantation in man. Brief review.

Authors:  M Ho
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

7.  A clear distinction between "immune activation of rejection" and "no immune activation" in liver transplant aspiration cytology.

Authors:  C L Greene; I Fehrman; G W Tillery; B S Husberg; G B Klintmalm
Journal:  Transplant Proc       Date:  1988-08       Impact factor: 1.066

8.  A longitudinal study of the serological and virological status of 18 women infected with cytomegalovirus.

Authors:  P D Griffiths; S Stagno; D W Reynolds; C A Alford
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

9.  A prospective study of cytomegalovirus and herpes simplex virus disease in renal transplant recipients.

Authors:  D P Walker; M Longson; N P Mallick; R W Johnson
Journal:  J Clin Pathol       Date:  1982-11       Impact factor: 3.411

10.  Cell-mediated immunity in mice with primary, secondary and latent herpes simplex virus infection.

Authors:  J M Darville; W A Blyth
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.